See the DrugPatentWatch profile for haldol
Haldol, a brand-name antipsychotic medication, is available as a generic, with its active ingredient being haloperidol [1].
When Does Haldol Patent Expire?
The original patents for haloperidol have long expired, allowing for generic versions to be manufactured and sold [2]. The development of generic medications is a standard process once brand-name drug patents lapse.
Where Can I Find Information on Haloperidol Patents?
Information regarding drug patents, including those for haloperidol and its active ingredient, can be found on resources like DrugPatentWatch.com [3]. These platforms track patent expiration dates and intellectual property information for pharmaceuticals.
What Are the Different Formulations of Haloperidol Available?
Haloperidol is available in various forms, including oral tablets, oral solution, and an injectable form, which can be administered intramuscularly or intravenously [1].
What is Haloperidol Used For?
Haloperidol is prescribed to manage psychotic disorders, including schizophrenia. It is also used to control motor and verbal tics in individuals with Tourette's syndrome and to treat severe behavioral problems in children who have not responded to other treatments [1].
What Are the Potential Side Effects of Haloperidol?
Common side effects of haloperidol may include drowsiness, dizziness, restlessness, or movement problems like tremors and muscle stiffness [1]. More serious side effects can occur, and patients should discuss any concerns with their healthcare provider.
Who Manufactures Generic Haloperidol?
Numerous pharmaceutical companies manufacture generic versions of haloperidol. Specific manufacturers can vary by region and availability.
How Does Generic Haloperidol Compare to Brand-Name Haldol?
Generic haloperidol contains the same active ingredient, haloperidol, and is bioequivalent to the brand-name drug Haldol. This means it is expected to have the same safety and efficacy profile. Generic medications are typically more affordable than their brand-name counterparts [4].